| Followers | 65 |
| Posts | 10174 |
| Boards Moderated | 0 |
| Alias Born | 03/29/2015 |
Sunday, January 05, 2025 7:40:35 PM
As will I... lol. Amazing to be back at a share price where we will be grateful to get to a buck
After more than 11 years invested in NWBO getting to 1 dollar a share with TLD already in the rear view mirror is not much to be amazed at or grateful for. It is far less than we have the right to expect to see waiting for us as the prize for staying in long after others dropped out and for finishing this race.
Now if NWBO can keep $1+ and never go below it again, that is a start and barely that.
Unless one is at least half a trader on this stock (which even a very vocal long admitted to being this week) the getting to $1 doesn’t matter, again it’s holding the $1 and marching forward.
As soon as MHRA approval hits, NWBO management needs to start controlling the narrative and start actively and visibly supporting the buy and hold shareholders like me (and I hope like you) who got stabbed in the back by the damned traders, NWBO management undercutting our rallies with missteps or sticking a pin in the balloon, and yes, maybe some shorts too.
Too many people are jaded and ready to say ‘I can’t beat do I’ll join them’ and sell into the rally.
MHRA approval, not later is the time for this management team to show up for those who did the right things whatever they said and not (as they have every other rally) those who said the right things but did the opposite by selling the rally.
So let’s see that big combination of news and a CLEAR plan for commercialization etc. No more coyness, no ‘someday’ but the hour and the day we hear from MHRA.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
